Purushotham Guroji

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 26, 2022
Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism.

Ritesh K Srivastava, Purushotham Guroji, Lin Jin

Pageof 1

Frequent Collaborators

1 joint publications

Ritesh K Srivastava

1 joint publications

Lin Jin

1 joint publications

M Shahid Mukhtar

1 joint publications

Mohammad Athar